Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
Summary
This trial is testing whether a more intense electrical current can help people with Alzheimer's disease more than the standard current.
Who is the study for?
This trial is for individuals with mild to moderate Alzheimer's Disease, who score between 18 and 25 on the MoCA test, indicating their cognitive abilities. They must also have a certain score on the Cambridge Naming Task. People with significant heart disease, alcohol or drug abuse history, stroke or traumatic brain injury (TBI), or those with shunts or metal in their body cannot participate.
What is being tested?
The study is testing whether a stronger intensity of transcranial direct current stimulation (tDCS) at 4mA combined with naming training can improve language skills better than the conventional level of 2mA in people living with Alzheimer's Disease.
What are the potential side effects?
While tDCS is generally considered safe, potential side effects may include mild tingling, itching or burning sensation on the scalp where electrodes are placed; headache; fatigue; and nausea.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Naming Training
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Placebo Group
Group I: 4mA StimulationExperimental Treatment1 Intervention
Group II: 2mA StimulationActive Control1 Intervention
Group III: SHAMPlacebo Group1 Intervention
Find a Location
Who is running the clinical trial?
Alzheimer's SocietyOTHER
9 Previous Clinical Trials
6,361 Total Patients Enrolled
BaycrestLead Sponsor
44 Previous Clinical Trials
6,419 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have never had a stroke or traumatic brain injury.
Research Study Groups:
This trial has the following groups:- Group 1: 4mA Stimulation
- Group 2: 2mA Stimulation
- Group 3: SHAM
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger